Silex Systems (SILXY) Stock Price, News & Analysis

Company Overview

Silex Systems Limited is an Australian technology company focused on commercializing advanced laser-based isotope separation technology. Its principal technology, known as SILEX, is designed to enrich uranium by using lasers to selectively separate isotopes. The company’s work is aimed at supporting a potentially more flexible and energy-efficient approach to uranium enrichment and nuclear fuel production.

Silex has licensed the SILEX technology for development and commercialization through Global Laser Enrichment, a venture involving Silex and Cameco. The technology is being advanced for potential use in the production of natural uranium, low-enriched uranium and high-assay low-enriched uranium, which may be used in conventional and next-generation nuclear reactors. Commercial deployment remains subject to technical development, regulatory approvals and other project requirements.

In addition to its uranium-enrichment activities, Silex Systems has pursued applications of its isotope-separation expertise in silicon purification and quantum technology. Through its subsidiary Translucent, the company has developed technologies for producing highly purified silicon materials intended for use in advanced semiconductor and quantum-computing applications. Silex Systems is headquartered in Australia and is listed on the Australian Securities Exchange, with its securities also traded in the United States.

Key Stats

• Today's Range: $13.05 to $13.48
• 50-Day Range: $12.98 to $20.83
• 52-Week Range: $12.69 to $35.50
• Volume: 10,031 shs
• Average Volume: 9,766 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Technology
• Industry: Semiconductors & Semiconductor Equipment
• Sub-Industry: Semiconductors
• Current Symbol: OTCMKTS:SILXY
• CIK: N/A
• Web: www.silex.com.au
• Phone: (129) 704-8888
• Fax: N/A
• Employees: 23,892
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A